Fintel reports that on August 14, 2023, Barclays maintained coverage of Corteva (NYSE:CTVA) with a Overweight recommendation.
Analyst Price Forecast Suggests 36.77% Upside
As of August 2, 2023, the average one-year price target for Corteva is 71.14. The forecasts range from a low of 57.57 to a high of $86.10. The average price target represents an increase of 36.77% from its latest reported closing price of 52.01.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Corteva is 18,852MM, an increase of 7.54%. The projected annual non-GAAP EPS is 3.19.
What is the Fund Sentiment?
There are 2117 funds or institutions reporting positions in Corteva. This is a decrease of 13 owner(s) or 0.61% in the last quarter. Average portfolio weight of all funds dedicated to CTVA is 0.36%, a decrease of 4.56%. Total shares owned by institutions increased in the last three months by 1.24% to 685,178K shares. 
The put/call ratio of CTVA is 0.56, indicating a bullish outlook.
What are Other Shareholders Doing?
Capital World Investors holds 36,747K shares representing 5.18% ownership of the company. In it's prior filing, the firm reported owning 23,297K shares, representing an increase of 36.60%. The firm increased its portfolio allocation in CTVA by 56.93% over the last quarter.
Aristotle Capital Management holds 26,499K shares representing 3.73% ownership of the company. In it's prior filing, the firm reported owning 26,899K shares, representing a decrease of 1.51%. The firm decreased its portfolio allocation in CTVA by 9.29% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 22,095K shares representing 3.11% ownership of the company. In it's prior filing, the firm reported owning 21,841K shares, representing an increase of 1.15%. The firm decreased its portfolio allocation in CTVA by 4.16% over the last quarter.
VIMSX - Vanguard Mid-Cap Index Fund Investor Shares holds 16,663K shares representing 2.35% ownership of the company. In it's prior filing, the firm reported owning 16,710K shares, representing a decrease of 0.28%. The firm decreased its portfolio allocation in CTVA by 0.96% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 16,633K shares representing 2.34% ownership of the company. In it's prior filing, the firm reported owning 16,517K shares, representing an increase of 0.70%. The firm decreased its portfolio allocation in CTVA by 4.18% over the last quarter.
Corteva Background Information
(This description is provided by the company.)
Corteva Agriscience is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry - including a balanced and diverse mix of seed, crop protection and digital solutions focused on maximizing productivity to enhance yield and profitability. With some of the most recognized brands in agriculture and an industry-leading product and technology pipeline well positioned to drive growth, the company is committed to working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. Corteva Agriscience became an independent public company on June 1, 2019 and was previously the Agriculture Division of DowDuPont.
Additional reading:
- Management Deferred Compensation Plan (Amended and Restated Effective January 1, 2024) Adopted: June 9, 2023
- AMENDMENT TO THE RETIREMENT SAVINGS RESTORATION PLAN Adopted: June 9, 2023
- Corteva, Inc. Consolidated Statements of Operations (Dollars in millions, except per share amounts)
- 1 News Release 2Q/1H 2023 Corteva Reports Second Quarter and First Half 2023 Results, Updates Full-Year Net Sales and Earnings Guidance • Strong Seed segment performance more than offset Crop Protection headwinds in 1H • Full Year forecast3 reflects
- Second Supplemental Indenture, dated as of May 15, 2023, between EIDP, Inc. and U.S. Bank Trust Company, National Association, as trustee.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
